Study guide

8.3 Body Fluid Compartments, Sodium/Water Homeostasis, and Potassium Dynamics

NPLEX Part I — Biomedical Sciences Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Pacing, and GEA Strategy

1.1 Overview of NPLEX Part I & NABNE Exam Structure 1.2 Deconstructing Biomedical Clinical Vignettes 1.3 General Exam Areas (GEAs) & Passing Standards

2 Chapter 2: Gross Anatomy & Musculoskeletal System

2.1 Musculoskeletal Anatomy of Upper and Lower Extremities 2.2 Structural Anatomy of Head, Neck, Thorax, and Abdomen 2.3 Pelvic Architecture, Perineal Anatomy, and Articular Structures

3 Chapter 3: Histology & Microscopic Anatomy

3.1 Histology of Epithelial, Connective, and Muscular Tissues 3.2 Microscopic Structure of Gastrointestinal, Renal, and Endocrine Organs 3.3 Microscopic Anatomy of Integument, Lymphoid Tissues, and Respiratory Epithelium

4 Chapter 4: Neuroanatomy & Special Senses

4.1 Cranial Nerves, Nuclei, and Peripheral Distribution 4.2 Spinal Cord Tracts, Brainstem Circuits, and Motor/Sensory Pathways 4.3 Cerebral Cortex, Basal Ganglia, Limbic System, and Autonomic Nervous System 4.4 Neuroanatomy of Vision, Audition, Vestibular Function, and Olfaction/Gustation

5 Chapter 5: Embryology & Developmental Anatomy

5.1 Gametogenesis, Fertilization, Blastulation, and Germ Layer Derivatives 5.2 Organogenesis: Cardiovascular and Respiratory System Development 5.3 Gastrointestinal, Urogenital, and Craniofacial Embryology

6 Chapter 6: Cellular & General Physiology

6.1 Membrane Transport Mechanics, Resting Potentials, and Ion Channels 6.2 Action Potential Propagation and Synaptic Transmission 6.3 Excitation-Contraction Coupling in Skeletal, Cardiac, and Smooth Muscle

7 Chapter 7: Cardiovascular & Respiratory Physiology

7.1 Cardiac Electrophysiology, ECG, and Mechanical Cardiac Cycle 7.2 Hemodynamics, Peripheral Resistance, and Blood Pressure Control 7.3 Pulmonary Mechanics, Lung Volumes, and Gas Exchange Dynamics 7.4 Transport of Oxygen/CO2 and Neural/Chemical Control of Breathing

8 Chapter 8: Renal, Fluid, & Acid-Base Physiology

8.1 Glomerular Filtration Rate and Tubular Reabsorption/Secretion Mechanics 8.2 Countercurrent Multiplication, Osmoregulation, and Urine Concentration 8.3 Body Fluid Compartments, Sodium/Water Homeostasis, and Potassium Dynamics 8.4 Renal & Respiratory Acid-Base Regulation and Compensation Mechanisms

9 Chapter 9: Gastrointestinal, Endocrine, & Reproductive Physiology

9.1 GI Motility, Secretory Functions, Digestion, and Nutrient Absorption 9.2 Hypothalamic-Pituitary Axes, Adrenal Gland, and Thyroid Physiology 9.3 Endocrine Pancreas, Glucose Regulation, Calcium/Phosphate Homeostasis 9.4 Male and Female Reproductive Endocrinology and Menstrual Cycle Regulation

10 Chapter 10: Enzymology, Bioenergetics, & Carbohydrate/Lipid Metabolism

10.1 Enzyme Kinetics, Catalytic Mechanisms, and Vitamin Cofactors 10.2 Glycolysis, Pyruvate Dehydrogenase, TCA Cycle, and Oxidative Phosphorylation 10.3 Glycogen Metabolism, Gluconeogenesis, and Pentose Phosphate Pathway 10.4 Fatty Acid Synthesis, Beta-Oxidation, Ketogenesis, and Lipoprotein Transport

11 Chapter 11: Amino Acid/Nucleotide Metabolism & Clinical Genetics

11.1 Amino Acid Degradation, Transamination, and Urea Cycle Disorders 11.2 Purine and Pyrimidine Synthesis, Salvage, and Gout Pathophysiology 11.3 Mendelian Inheritance, Chromosomal Abnormalities, and Molecular Genetics

12 Chapter 12: Immunology & Immunopathology

12.1 Innate Immune Barriers, Phagocytosis, Cellular Pattern Recognition, and Complement System 12.2 Adaptive Immunity: T-Cell & B-Cell Activation, MHC Restriction, and Antibodies 12.3 Types I-IV Hypersensitivity Reactions and Mechanisms of Autoimmunity 12.4 Immunodeficiency Syndromes, Tumor/Transplant Immunology, and Vaccine Types

13 Chapter 13: Medical Microbiology

13.1 Medical Bacteriology: Gram-Positive, Gram-Negative, and Atypical Bacteria 13.2 Medical Virology: DNA, RNA, Retroviruses, and Viral Pathogenesis 13.3 Medical Mycology: Cutaneous, Systemic, and Opportunistic Fungal Infections 13.4 Medical Parasitology: Protozoan and Helminthic Pathogens

14 Chapter 14: General Pathology & Neoplasia

14.1 Cellular Adaptation, Reversible/Irreversible Injury, Necrosis, and Apoptosis 14.2 Acute and Chronic Inflammation, Chemical Mediators, and Tissue Healing 14.3 Neoplasia: Benign vs Malignant Features, Carcinogenesis, Oncogenes, and Tumor Suppressors

15 Chapter 15: Systems Pathology & Disease Mechanisms

15.1 Pathophysiology of Atherosclerosis, Heart Failure, COPD, and Pneumonias 15.2 Glomerulonephritis, Inflammatory Bowel Disease, and Hepatorenal Disease Pathophysiology 15.3 Endocrine Disorders, Neurodegenerative Pathology, and Epidemiological Principles 15.4 Hematopoietic System Pathology: Anemias, Coagulopathies, and Hematologic Neoplasms 15.5 Immunological System Pathology: Autoimmune, Amyloid, and Systemic Immune-Mediated Disease 15.6 Integumentary System Pathology: Inflammatory Dermatoses, Blistering Disorders, and Skin Neoplasms 15.7 Musculoskeletal System Pathology: Metabolic Bone Disease, Arthropathies, and Bone Neoplasms 15.8 Reproductive System Pathology: Endocrine, Inflammatory, and Neoplastic Disorders of the Reproductive Tract

8.3 Body Fluid Compartments, Sodium/Water Homeostasis, and Potassium Dynamics

Key Takeaways Explain This Topic AI

Total Body Water (TBW) constitutes ~60% of total body weight, divided into Intracellular Fluid (ICF, 2/3 of TBW) and Extracellular Fluid (ECF, 1/3 of TBW, composed of 3/4 interstitial fluid and 1/4 blood plasma).

Fluid shifts between ICF and ECF are dictated by osmotic gradients across cell membranes, classically analyzed via Darrow-Yannet diagrams into iso-osmotic, hyper-osmotic, and hypo-osmotic volume expansion and contraction.

Serum sodium concentration reflects water balance rather than total body sodium quantity; rapid correction of hyponatremia risks osmotic demyelination syndrome (CPM), whereas rapid correction of hypernatremia risks cerebral edema.

Potassium is 98% intracellular; acute internal distribution is regulated by Na+/K+ ATPase activity (promoted by insulin, beta-2 agonists, and alkalosis), while chronic external balance is controlled by renal principal cell secretion driven by aldosterone and tubular flow rate.

Parathyroid hormone (PTH) regulates divalent ions at the renal tubule by downregulating Na+/Pi-2a symporters in the PCT (causing phosphaturia) and upregulating apical TRPV5 Ca2+ channels in the DCT (promoting calcium reabsorption).

Last updated: July 2026

Loading diagram... Body Fluid Compartments and Transcellular Potassium Distribution

8.3 Body Fluid Compartments, Sodium/Water Homeostasis, and Potassium Dynamics

Maintaining fluid volume, osmolality, and electrolyte concentrations across body fluid compartments is vital for cellular integrity, neuromuscular excitability, and systemic perfusion. The body regulates water and electrolytes through complex thermodynamic fluid shifts and nephron transport mechanisms.

Body Fluid Compartments and Volume Distribution

In a standard adult male, Total Body Water (TBW) accounts for approximately 60 % 60\% 60% of body weight ( 50 % 50\% 50% in adult females due to higher body fat fraction; 75 – 80 % 75–80\% 75–80% in infants). Total Body Weight (100%)

  • └── Total Body Water (60% of weight)
  • ├── Intracellular Fluid (ICF: 40% of weight = 2/3 of TBW)
  • └── Extracellular Fluid (ECF: 20% of weight = 1/3 of TBW)
  • ├── Interstitial Fluid (ISF: 15% of weight = 3/4 of ECF)
  • └── Plasma Volume (PV: 5% of weight = 1/4 of ECF)
  • The "60-40-20 Rule"

Total Body Water (TBW) : 60 % 60\% 60% of total body weight ( ≈ 42 L \approx 42\text{ L} ≈ 42 L in a 70-kg individual).

Intracellular Fluid (ICF) : 40 % 40\% 40% of total body weight ( 2 / 3 2/3 2/3 of TBW, ≈ 28 L \approx 28\text{ L} ≈ 28 L ). Maintained by cell membrane Na + / K + \text{Na}^+/\text{K}^+ Na + / K + ATPase pumps. Major cations: K + \text{K}^+ K + and Mg 2 + \text{Mg}^{2+} Mg 2 + ; major anions: organic phosphates and proteins.

Extracellular Fluid (ECF) : 20 % 20\% 20% of total body weight ( 1 / 3 1/3 1/3 of TBW, ≈ 14 L \approx 14\text{ L} ≈ 14 L ). Major cation: Na + \text{Na}^+ Na + ; major anions: Cl − \text{Cl}^- Cl − and HCO 3 − \text{HCO}_3^- HCO 3 − ​ .

Interstitial Fluid (ISF) : 3 / 4 3/4 3/4 of ECF ( 15 % 15\% 15% of body weight, ≈ 10.5 L \approx 10.5\text{ L} ≈ 10.5 L ).

Plasma Volume (PV) : 1 / 4 1/4 1/4 of ECF ( 5 % 5\% 5% of body weight, ≈ 3.5 L \approx 3.5\text{ L} ≈ 3.5 L ).

Total Blood Volume : Blood Volume = Plasma Volume 1 − Hematocrit ≈ 5.0 L \text{Blood Volume} = \frac{\text{Plasma Volume}}{1 - \text{Hematocrit}} \approx 5.0\text{ L} Blood Volume = 1 − Hematocrit Plasma Volume ​ ≈ 5.0 L .

Compartment Measurement (Indicator Dilution Principle)

Compartment volumes are measured experimentally by injecting an indicator mass ( Q Q Q ) and measuring plasma concentration ( C C C ) after equilibrium ( V = Q / C V = Q / C V = Q / C ):

TBW Markers : Tritiated water ( H 3 O \text{H}_3\text{O} H 3 ​ O ), Deuterium oxide ( D 2 O \text{D}_2\text{O} D 2 ​ O ), Antipyrine.

ECF Markers : Inulin, Mannitol, Radiomeglumine (substances that cross capillary walls but cannot cross cell membranes).

Plasma Volume Markers : Evans blue dye, Radiolabeled Serum Albumin ( 125 I-RISA ^{125}\text{I-RISA} 125 I-RISA ).

Calculated Volumes : ICF = TBW − ECF \text{ICF} = \text{TBW} - \text{ECF} ICF = TBW − ECF ; Interstitial Volume = ECF − Plasma Volume \text{Interstitial Volume} = \text{ECF} - \text{Plasma Volume} Interstitial Volume = ECF − Plasma Volume .

Fluid Shift Scenarios (Darrow-Yannet Kinetics)

Water moves freely across cell membranes to equalize osmolality between ICF and ECF. Clinical fluid disturbances alter ECF osmolarity or volume, driving secondary water shifts into or out of the ICF:

  • Scenario Primary Cause ECF Volume ICF Volume ECF/ICF Osmolarity
  • Iso-osmotic Volume Contraction Severe diarrhea, acute hemorrhage, vomiting ↓ \downarrow ↓ No Change No Change

Hyper-osmotic Volume Contraction Profuse sweating, fever, Diabetes Insipidus ↓ \downarrow ↓ ↓ \downarrow ↓ ↑ \uparrow ↑

Hypo-osmotic Volume Contraction Adrenal insufficiency (aldosterone deficiency) ↓ \downarrow ↓ ↑ \uparrow ↑ ↓ \downarrow ↓

Iso-osmotic Volume Expansion Infusion of 0.9% Normal Saline ↑ \uparrow ↑ No Change No Change

Hyper-osmotic Volume Expansion Hypertonic saline infusion (3% NaCl), high salt diet ↑ \uparrow ↑ ↓ \downarrow ↓ ↑ \uparrow ↑

  • Hypo-osmotic Volume Expansion SIADH, primary psychogenic polydipsia ↑ \uparrow ↑ ↑ \uparrow ↑ ↓ \downarrow ↓
  • Sodium Homeostasis and Osmotic Correction Hazards

Sodium ( Na + \text{Na}^+ Na + ) is the principal extracellular cation and primary determinant of ECF volume. Serum sodium concentration ( [ Na + ] [\text{Na}^+] [ Na + ] , normal 135 – 145 mEq/L 135–145\text{ mEq/L} 135–145 mEq/L ) reflects water balance relative to sodium, rather than total body sodium quantity.

Hyponatremia ( [ Na + ] < 135 mEq/L [\text{Na}^+] < 135\text{ mEq/L} [ Na + ] < 135 mEq/L )

Pathophysiology : Hypo-osmolar ECF causes water to shift into brain cells, producing cerebral edema, headache, confusion, seizures, and coma.

Correction Hazard (Osmotic Demyelination Syndrome) : Overly rapid correction of chronic hyponatremia with hypertonic saline causes water to shift rapidly out of brain cells into the hypertonic ECF. Demethylation of pontine neurons results in Osmotic Demyelination Syndrome (ODS / Central Pontine Myelinolysis) , manifesting as irreversible spastic quadriparesis, pseudobulbar palsy, and "locked-in" syndrome. Correction rate must not exceed 8 – 10 mEq/L 8–10\text{ mEq/L} 8–10 mEq/L per 24 hours .

Hypernatremia ( [ Na + ] > 145 mEq/L [\text{Na}^+] > 145\text{ mEq/L} [ Na + ] > 145 mEq/L )

Pathophysiology : Hyper-osmolar ECF draws water out of brain cells, causing neuronal shrinkage and intracranial hemorrhage.

Correction Hazard (Cerebral Edema) : Overly rapid administration of hypotonic fluids causes rapid water influx into brain cells that have accumulated intracellular idiogenic osmoles, triggering severe cerebral edema and herniation.

Potassium Dynamics: Internal and External Homeostasis

Total body potassium is ≈ 3500 mEq \approx 3500\text{ mEq} ≈ 3500 mEq . Potassium is 98 % 98\% 98% intracellular ( ≈ 140 mEq/L \approx 140\text{ mEq/L} ≈ 140 mEq/L ) and 2 % 2\% 2% extracellular ( 3.5 – 5.0 mEq/L 3.5–5.0\text{ mEq/L} 3.5–5.0 mEq/L ). Maintaining this steep gradient across the cell membrane is essential for resting membrane potential. Extra-Renal Shifts (Internal Homeostasis) Renal Excretion (External Homeostasis)

  • Inward Shift (Lower K+): Insulin, Beta-2, Alkalosis Principal Cells: Aldosterone, ENaC, ROMK
  • Outward Shift (Higher K+): Acidosis, Beta-blockers High Tubular Flow Rate
  • 1. Internal Potassium Distribution (Transcellular Shifts)

Factors Shifting K + \text{K}^+ K + INTO Cells (Cause Hypokalemia) :

Insulin : Directly stimulates cell membrane Na + / K + \text{Na}^+/\text{K}^+ Na + / K + ATPase pumps.

β 2 \beta_2 β 2 ​ -Adrenergic Agonists (e.g., albuterol): Increase intracellular cAMP to stimulate Na + / K + \text{Na}^+/\text{K}^+ Na + / K + ATPase.

Alkalosis : Extracellular H + \text{H}^+ H + exits cells in exchange for intracellular K + \text{K}^+ K + entering cells.

Factors Shifting K + \text{K}^+ K + OUT of Cells (Cause Hyperkalemia) :

Insulin Deficiency and β \beta β -Blockers .

Acidosis (Inorganic): H + \text{H}^+ H + enters cells to be buffered, displacing K + \text{K}^+ K + into ECF.

Hyperosmolality : Water outflow creates solvent drag, pulling K + \text{K}^+ K + out of cells.

Cell Lysis : Rhabdomyolysis, tumor lysis syndrome, severe hemolysis.

2. External Potassium Balance (Renal Handling)

Filtration & Early Reabsorption : Freely filtered at glomerulus; PCT reabsorbs ≈ 65 % \approx 65\% ≈ 65% , and TAL reabsorbs ≈ 20 % \approx 20\% ≈ 20% .

Distal Regulation : Renal excretion is regulated in the late DCT and collecting duct principal cells .

Factors Stimulating Principal Cell K + \text{K}^+ K + Secretion :

Aldosterone : Upregulates apical ROMK and basolateral Na + / K + \text{Na}^+/\text{K}^+ Na + / K + ATPase pumps.

High Luminal Flow Rate : Rapid tubular flow washes away secreted K + \text{K}^+ K + , maintaining a steep concentration gradient for ROMK secretion.

High Intracellular K + \text{K}^+ K + and Lumen-Negative Voltage (driven by ENaC Na + \text{Na}^+ Na + reabsorption).

  • Renal Calcium and Phosphate Handling
  • Phosphate Handling

Reabsorption : ≈ 85 % \approx 85\% ≈ 85% of filtered phosphate is reabsorbed in the PCT via apical Sodium-Phosphate Cotransporter 2a (Na+/Pi-2a) .

Hormonal Regulation : Parathyroid Hormone (PTH) binds basolateral receptors on PCT cells, activating cAMP to induce endocytosis and degradation of Na+/Pi-2a cotransporters, producing phosphaturia (inhibiting phosphate reabsorption). FGF-23 similarly promotes phosphate excretion.

Calcium Handling

Reabsorption : ≈ 65 % \approx 65\% ≈ 65% reabsorbed in PCT (passive paracellular), ≈ 25 – 30 % \approx 25–30\% ≈ 25–30% reabsorbed in TAL (paracellular, driven by NKCC2 lumen-positive potential), and ≈ 5 – 10 % \approx 5–10\% ≈ 5–10% reabsorbed in DCT (active transcellular).

Hormonal Regulation : PTH acts on the DCT to stimulate apical TRPV5 calcium channels and intracellular calbindin-D28k , enhancing active calcium reabsorption (hypocalciuric effect).